MedPath

Effect of Number of Meals on Metabolism After Weight Loss Surgery

Not Applicable
Completed
Conditions
Morbid Obesity
Interventions
Other: Solid Meal
Other: Liquid Meal
Drug: Acetaminophen
Other: Single, 600 kcal meal
Other: Multiple, 200 kcal meals
Registration Number
NCT02929212
Lead Sponsor
Columbia University
Brief Summary

The purpose of this study is to determine the effect of meal size and texture on the levels of incretin hormone, GLP-1, after Gastric Bypass Surgery (GBP). Patterns of food intake change after bariatric surgery and patients often eat multiple small low-calorie meals, a pattern that may affect blood glucose as well as incretin levels. Whether the release of GLP-1 after an oral challenge or a single liquid meal has any physiological relevance in 'real life' setting of multiple small meals diet is unclear.

Detailed Description

The main goal is to study the effect of meal size and texture on incretin levels after GBP. Patients will be studied before GBP (T0) and 12-15 months after GBP (T1). At T0 and T1, patients will come for 2 study days for 8 hours: On one study day, a single meal will be served, on the second study day, three small meals, with the order of the conditions randomly assigned. The total amount of calories (600 kcal) and the over all nutrient composition (55% CHO, 15 % protein, 30% fat) will be equivalent between conditions. The meals will be either all solid or all liquid. Patients enrolled in the study will be randomly assigned to solid or liquid test meals.

Recruitment and data gathering for this study were performed at St. Luke's Hospital in New York, NY. Data Analysis was performed at Columbia University Medical Center in New York, NY.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria

morbidly obese individuals, BMI above 35 and less than 50 kg/m2 who chose GBP as treatment for their obesity

  • Must be able to attend all study visits at St. Luke's Roosevelt Hospital Center in Manhattan, New York City
  • Individuals with or without Type 2 Diabetes Mellitus are eligible
Read More
Exclusion Criteria
  • Patients with abnormal thyroid, renal function, known malabsorption syndrome or a seizure disorder requiring anti epileptic therapy, and/or elevation of liver enzymes three times above the normal limit.
  • Patients with intestinal conditions such as chronic diarrhea, diverticulitis, or irritable bowel syndrome.
  • Currently pregnant or nursing.
  • Known cardiovascular disease.
  • Patient with current mucosal (gastrointestinal, respiratory, urogenital) or skin (cellulitis) infection
  • Any other condition which, in the opinion of the investigators, may make the candidate unsuitable for participation in this study.
  • past history of severe food allergy
  • History of Type 1 Diabetes Mellitus
  • Individuals taking insulin, thiazolidinedione, exenatide, or DPP-IV inhibitors
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Solid Meal Study Group ASolid MealPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as one, 600 kcal, meal.
Solid Meal Study Group AAcetaminophenPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as one, 600 kcal, meal.
Solid Meal Study Group ASingle, 600 kcal mealPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as one, 600 kcal, meal.
Liquid Meal Study Group ALiquid MealPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as one, 600 kcal, meal
Liquid Meal Study Group AAcetaminophenPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as one, 600 kcal, meal
Liquid Meal Study Group ASingle, 600 kcal mealPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as one, 600 kcal, meal
Solid Meal Study Group BSolid MealPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as three, 200 kcal, meals.
Solid Meal Study Group BMultiple, 200 kcal mealsPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as three, 200 kcal, meals.
Liquid Meal Study Group BLiquid MealPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as three, 200 kcal, meals.
Liquid Meal Study Group BAcetaminophenPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as three, 200 kcal, meals.
Liquid Meal Study Group BMultiple, 200 kcal mealsPatients Pre and Post-GBP who are randomly assigned to receive liquid meals on meal study days, given as three, 200 kcal, meals.
Solid Meal Study Group BAcetaminophenPatients Pre and Post-GBP who are randomly assigned to receive solid meals on study days given as three, 200 kcal, meals.
Primary Outcome Measures
NameTimeMethod
Difference in GLP-1 levels before and after gastric bypass surgery12-15 months

Investigators will assess GLP-1 levels in subjects pre and post-GBP

Difference in glucose levels before and after gastric bypass surgery12-15 months

Investigators will assess glucose in subjects pre and post-GBP

Difference in insulin levels before and after gastric bypass surgery12-15 months

Investigators will assess insulin levels in subjects pre and post-GBP

Secondary Outcome Measures
NameTimeMethod
Difference in GLP-1 levels in solid vs liquid meals12-15 months

Investigators will assess GLP-1 levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points

Difference in glucose levels in solid vs liquid meals12-15 months

Investigators will assess glucose levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points

Difference in insulin levels in solid vs liquid meals12-15 months

Investigators will assess insulin levels in subjects eating either liquid or solid meals at both pre-surgery and post-surgery time points

Trial Locations

Locations (1)

New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath